Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98 USD | +1.77% |
|
+18.50% | +37.22% |
Jul. 08 | Ligand to Acquire Apeiron for $100 Million in Cash, Plus Up to $28 Million Based on Royalties | MT |
Jul. 08 | Ligand Pharmaceuticals Incorporated Revises Earnings Guidance for the Year 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.22% | 1.76B | |
+60.25% | 841B | |
+38.56% | 625B | |
-4.49% | 360B | |
+18.30% | 327B | |
+9.64% | 300B | |
+14.15% | 242B | |
+3.11% | 228B | |
+16.98% | 227B | |
+12.87% | 174B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Transcript : Ligand Pharmaceuticals Incorporated - Shareholder/Analyst Call